annb0t
Top 20
Immutep (ASX:IMM) First Half 2023 Results
Key Financial Results
Net loss: AU$20.6m (loss widened by 27% from 1H 2022). AU$0.024 loss per share (further deteriorated from AU$0.019 loss in 1H 2022). earnings-and-revenue-growth
All figures shown in the chart above are for the trailing 12 month (TTM) period
Immutep Earnings Insights
Looking ahead, revenue is forecast to grow 93% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Biotechs industry in Australia.
P...
>>> Read more: Immutep First Half 2023 Earnings: AU$0.024 loss per share (vs AU$0.019 loss in 1H 2022)
Key Financial Results
Net loss: AU$20.6m (loss widened by 27% from 1H 2022). AU$0.024 loss per share (further deteriorated from AU$0.019 loss in 1H 2022). earnings-and-revenue-growth
All figures shown in the chart above are for the trailing 12 month (TTM) period
Immutep Earnings Insights
Looking ahead, revenue is forecast to grow 93% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Biotechs industry in Australia.
P...
>>> Read more: Immutep First Half 2023 Earnings: AU$0.024 loss per share (vs AU$0.019 loss in 1H 2022)
